vs

Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and PubMatic, Inc. (PUBM). Click either name above to swap in a different company.

PubMatic, Inc. is the larger business by last-quarter revenue ($80.0M vs $75.5M, roughly 1.1× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -6.4%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $11.3M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 9.5%).

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

PubMatic, Inc. develops and implements online advertising software and strategies for the digital publishing and advertising industry. PubMatic's sell-side, real-time programmatic ad transaction advertising software puts publishers of websites, videos, and mobile apps into contact with ad buyers by using automated systems, while allowing users to opt-out of having their personal information collected on internet searches. PubMatic has a number of offices in countries around the world.

PBYI vs PUBM — Head-to-Head

Bigger by revenue
PUBM
PUBM
1.1× larger
PUBM
$80.0M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+34.1% gap
PBYI
27.7%
-6.4%
PUBM
More free cash flow
PBYI
PBYI
$3.1M more FCF
PBYI
$14.4M
$11.3M
PUBM
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
9.5%
PUBM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PBYI
PBYI
PUBM
PUBM
Revenue
$75.5M
$80.0M
Net Profit
Gross Margin
69.3%
68.2%
Operating Margin
22.7%
10.6%
Net Margin
Revenue YoY
27.7%
-6.4%
Net Profit YoY
EPS (diluted)
$0.26
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PBYI
PBYI
PUBM
PUBM
Q4 25
$75.5M
$80.0M
Q3 25
$54.5M
$68.0M
Q2 25
$52.4M
$71.1M
Q1 25
$46.0M
$63.8M
Q4 24
$59.1M
$85.5M
Q3 24
$80.5M
$71.8M
Q2 24
$47.1M
$67.3M
Q1 24
$43.8M
$66.7M
Net Profit
PBYI
PBYI
PUBM
PUBM
Q4 25
Q3 25
$8.8M
$-6.5M
Q2 25
$5.9M
$-5.2M
Q1 25
$3.0M
$-9.5M
Q4 24
Q3 24
$20.3M
$-912.0K
Q2 24
$-4.5M
$2.0M
Q1 24
$-4.8M
$-2.5M
Gross Margin
PBYI
PBYI
PUBM
PUBM
Q4 25
69.3%
68.2%
Q3 25
77.7%
62.6%
Q2 25
76.5%
62.6%
Q1 25
77.1%
59.9%
Q4 24
76.4%
70.8%
Q3 24
63.9%
64.5%
Q2 24
77.4%
62.6%
Q1 24
75.5%
61.9%
Operating Margin
PBYI
PBYI
PUBM
PUBM
Q4 25
22.7%
10.6%
Q3 25
17.6%
-12.4%
Q2 25
12.7%
-7.7%
Q1 25
8.7%
-18.6%
Q4 24
22.6%
17.3%
Q3 24
27.4%
-1.9%
Q2 24
-4.6%
-5.9%
Q1 24
-5.3%
-8.3%
Net Margin
PBYI
PBYI
PUBM
PUBM
Q4 25
Q3 25
16.2%
-9.5%
Q2 25
11.2%
-7.3%
Q1 25
6.5%
-14.9%
Q4 24
Q3 24
25.2%
-1.3%
Q2 24
-9.6%
2.9%
Q1 24
-11.0%
-3.7%
EPS (diluted)
PBYI
PBYI
PUBM
PUBM
Q4 25
$0.26
$0.14
Q3 25
$0.17
$-0.14
Q2 25
$0.12
$-0.11
Q1 25
$0.06
$-0.20
Q4 24
$0.40
$0.26
Q3 24
$0.41
$-0.02
Q2 24
$-0.09
$0.04
Q1 24
$-0.10
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PBYI
PBYI
PUBM
PUBM
Cash + ST InvestmentsLiquidity on hand
$97.5M
$145.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$130.3M
$262.6M
Total Assets
$216.3M
$680.2M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PBYI
PBYI
PUBM
PUBM
Q4 25
$97.5M
$145.5M
Q3 25
$94.4M
$136.5M
Q2 25
$96.0M
$90.5M
Q1 25
$93.2M
$101.8M
Q4 24
$101.0M
$100.5M
Q3 24
$96.7M
$78.9M
Q2 24
$96.8M
$73.5M
Q1 24
$107.2M
$80.2M
Total Debt
PBYI
PBYI
PUBM
PUBM
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
PBYI
PBYI
PUBM
PUBM
Q4 25
$130.3M
$262.6M
Q3 25
$115.3M
$245.1M
Q2 25
$104.7M
$243.3M
Q1 25
$97.1M
$275.6M
Q4 24
$92.1M
$277.3M
Q3 24
$71.1M
$263.2M
Q2 24
$48.5M
$282.7M
Q1 24
$51.0M
$288.7M
Total Assets
PBYI
PBYI
PUBM
PUBM
Q4 25
$216.3M
$680.2M
Q3 25
$202.9M
$676.2M
Q2 25
$194.9M
$675.2M
Q1 25
$196.2M
$668.6M
Q4 24
$213.3M
$739.5M
Q3 24
$220.7M
$689.1M
Q2 24
$205.0M
$673.1M
Q1 24
$214.1M
$626.2M
Debt / Equity
PBYI
PBYI
PUBM
PUBM
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PBYI
PBYI
PUBM
PUBM
Operating Cash FlowLast quarter
$14.4M
$18.2M
Free Cash FlowOCF − Capex
$14.4M
$11.3M
FCF MarginFCF / Revenue
19.1%
14.1%
Capex IntensityCapex / Revenue
0.0%
8.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$41.7M
$66.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PBYI
PBYI
PUBM
PUBM
Q4 25
$14.4M
$18.2M
Q3 25
$9.7M
$32.4M
Q2 25
$14.1M
$14.9M
Q1 25
$3.6M
$15.6M
Q4 24
$15.6M
$18.0M
Q3 24
$11.0M
$19.1M
Q2 24
$1.0M
$11.9M
Q1 24
$11.2M
$24.3M
Free Cash Flow
PBYI
PBYI
PUBM
PUBM
Q4 25
$14.4M
$11.3M
Q3 25
$9.7M
$27.7M
Q2 25
$14.1M
$13.6M
Q1 25
$3.6M
$14.2M
Q4 24
$15.6M
$13.7M
Q3 24
$11.0M
$7.4M
Q2 24
$1.0M
$11.2M
Q1 24
$23.5M
FCF Margin
PBYI
PBYI
PUBM
PUBM
Q4 25
19.1%
14.1%
Q3 25
17.7%
40.8%
Q2 25
26.8%
19.1%
Q1 25
7.7%
22.2%
Q4 24
26.4%
16.1%
Q3 24
13.7%
10.3%
Q2 24
2.1%
16.7%
Q1 24
35.2%
Capex Intensity
PBYI
PBYI
PUBM
PUBM
Q4 25
0.0%
8.6%
Q3 25
0.0%
6.9%
Q2 25
0.0%
1.9%
Q1 25
0.1%
2.3%
Q4 24
0.0%
5.1%
Q3 24
0.0%
16.3%
Q2 24
0.0%
1.1%
Q1 24
0.0%
1.2%
Cash Conversion
PBYI
PBYI
PUBM
PUBM
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
6.06×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons